Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Transplantation Proceedings
|
January 1, 1998
Individualizing immunosuppression for heart transplantation: strategies for the next decade
H A Valantine
Transplantation Proceedings
|
October 1, 1995
Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin
H A Valantine
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 22, 2001
Role of CMV in transplant coronary artery disease and survival after heart transplantation
H A Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 1, 1995
Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound
H A Valantine
Cardiology Clinics
|
February 1, 1990
Long-term management and results in heart transplant recipients
H A Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 1, 1993
Rejection surveillance by Doppler echocardiography
H A Valantine
Current Opinion in Cardiology
|
May 21, 1998
Do calcium channel blockers and HMG-CoA reductase inhibitors attenuate allograft arteriopathy?
H A Valantine-von Kaeppler
Transplantation Proceedings
|
March 20, 1999
Prevention of chronic heart allograft rejection
H A Valantine-von Kaeppler
Intensive Care Medicine
|
January 1, 1989
Cardiac transplantation
H A Valantine, J S Schroeder
Circulation
|
October 7, 1997
HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?
H A Valantine, J S Schroeder
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Transplantation Proceedings
|
January 1, 1998
Individualizing immunosuppression for heart transplantation: strategies for the next decade
H A Valantine
Transplantation Proceedings
|
October 1, 1995
Prevention and treatment of cytomegalovirus disease in thoracic organ transplant patients: evidence for a beneficial effect of hyperimmune globulin
H A Valantine
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 22, 2001
Role of CMV in transplant coronary artery disease and survival after heart transplantation
H A Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
November 1, 1995
Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound
H A Valantine
Cardiology Clinics
|
February 1, 1990
Long-term management and results in heart transplant recipients
H A Valantine
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
May 1, 1993
Rejection surveillance by Doppler echocardiography
H A Valantine
Current Opinion in Cardiology
|
May 21, 1998
Do calcium channel blockers and HMG-CoA reductase inhibitors attenuate allograft arteriopathy?
H A Valantine-von Kaeppler
Transplantation Proceedings
|
March 20, 1999
Prevention of chronic heart allograft rejection
H A Valantine-von Kaeppler
Intensive Care Medicine
|
January 1, 1989
Cardiac transplantation
H A Valantine, J S Schroeder
Circulation
|
October 7, 1997
HMG-CoA reductase inhibitors reduce transplant coronary artery disease and mortality: evidence for antigen-independent mechanisms?
H A Valantine, J S Schroeder
Page
of 7